ArticleTherapeutic advances in gastroenterology2016

Cardiovascular risk assessment in the treatment of nonalcoholic steatohepatitis: a secondary analysis of the MOZART trial.

Steven C Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.